British Land appoints CFO
British Land, a property development and investment company, has brought Simon Carter on board as its new Chief Financial Officer. Simon will be replacing Lucinda Bell, who is planning to step down from the company and the board with an immediate effect.
Currently, Simon is the CFO at Logicor. He had previously held the role of finance director at Quintain Estates & Development. Simon has also worked with British Land. He had previously spent 10 years in the company in a variety of financial and strategic roles and was a member of the executive committee from 2012.
Dixons Carphone appoints Alex Baldock as group chief executive
Dixon’s Carphone has appointed Alex Baldock as its new group chief executive. Alex, who will succeed Sebastian James, will take on his responsibilities from April 2018.
Alex currently serves as the group chief executive at ShopDirect Plc. He has been holding this position since 2012. Speaking about Alex’s appointment, Ian Livingston, Chairman of Dixons Carphone plc, said, “The Board and I are delighted to welcome Alex Baldock to the Group. He has an outstanding track record in leading large, complex consumer-facing businesses. We wanted Alex for his strategic clarity, relentless execution and his ability to inspire people to get behind him at every step. We look forward to Alex bringing that leadership to the Group as we build on our market-leading positions.”
Little Mistress appoints new finance director
Pradeep Chotai, former UK finance and operations director at PVH, owner of Calvin Klein and Tommy Hilfiger, has joined Little Mistress Group as its new finance director. Chotai had joined the women’s wear brand on 23rd January 2018.
Prior to Little Mistress Group, Chotai was the UK finance and operations director for Tommy Hilfiger for 10 years until 2013. Following which, he had taken on the same role at PVH for three years. Chotai has also held various financial roles at Pepe Jeans for 12 years and has also consulted at a range of companies, such as, Maison Blanc and Brand Machine Group.
Miigen appoints new Finance Director ahead of £1 million fund-raising
Miigen, social platform for senior life living, has appointed entrepreneur Alasdair McGill as its new Finance Director. Although, Alasdair has been working with the Miigen since September 2017, he has recently joined the company in an official role. He will also retain his post as Co-Founder and Managing Director of Ashton McGill, his Dundee-based accountancy and consulting business.
Prior to Miigen, Alasdair has worked with EY before taking up the role of Financial Controller at a client firm and rising to the role of Group MD. Alasdair had also held the role of Head of Enterprise and Entrepreneurial Strategy at the University of Dundee. In this role, he had led the design and implementation of the University’s strategy and remains as its Entrepreneur in Residence.
Commenting on Alasdair’s appointment, Craig J Lemmon, co-founder Miigen said, “We are absolutely delighted to have been able to attract someone of Alasdair’s calibre to join the team and help us on the next stage of the Miigen journey. Although Alasdair’s core role will be his Finance Director responsibilities, he has unrivalled commercial experience at senior levels and he understands very well what it takes to start, run and grow a business.”
Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer
Biotechnology company, Orchard Therapeutics has appointed Frank Thomas as the new chief financial officer and chief business officer of the company. Frank will be responsible for the company’s global finance and business development teams.
Bringing over 20 years of experience to Orchard, Frank is described as an accomplished financial and business executive with an extensive set of capabilities. He holds a varied background that includes developing and executing capital markets strategies for private and public companies as well as experience in operations management, and corporate and business development.
Before joining Orchard, Frank had served as the president and chief operating officer of AMAG Pharmaceuticals. During his stint at AMAG, Frank had helped develop the business from a single product company in 2011 to one with a portfolio of commercial and development-stage products that generated more than $600 million in sales in 2017. He has also worked in the roles of chief operating officer and chief financial officer for Molecular Biometrics. Frank also serves on the board of directors of Zafgen and Spero Therapeutics. He is also the Chairman of the audit committees at both the companies.
Wey Education Appoints Barry Nichols-Gray Finance Director-Designate
Wey Education, an education services company, has appointed Barry Nichols-Gray as their new finance director-designate and company secretary. Barry will be taking on responsibilities of his role from April 2018. Prior to Wey Education, Barry had worked for the Financial Services Authority.